🇺🇸 FDA
Pipeline program

ETOPOSIDE, PACLITAXEL, IFOSFAMIDE, CISPLATIN, CARBOPLATIN

1407-GUCG

Phase 3 small_molecule active

Quick answer

ETOPOSIDE, PACLITAXEL, IFOSFAMIDE, CISPLATIN, CARBOPLATIN for Progressive or recurrent germ cell tumor (measurable or non-measurable) is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Cancer Prevention Pharma (Ireland) Limited
Indication
Progressive or recurrent germ cell tumor (measurable or non-measurable)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials